Estradiol measurement
|
phenotype |
|
Laboratory Procedure
|
21
|
75
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Abnormality of brain morphology
|
phenotype |
|
Anatomical Abnormality
|
104
|
131
|
0.100 |
None |
|
0 |
1
|
|
|
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.380 |
None |
0.875 |
8 |
|
2004 |
2018 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2017 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.540 |
None |
1.000 |
5 |
|
2008 |
2019 |
Epileptic encephalopathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
187
|
126
|
0.130 |
None |
1.000 |
3 |
|
2010 |
2016 |
Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1215
|
339
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2019 |
Miller Dieker syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
182
|
9
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2012 |
Myotonic Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
155
|
4
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
X-linked infantile spasms
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
53
|
122
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
High grade glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
190
|
15
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
West Syndrome
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
149
|
28
|
0.410 |
None |
1.000 |
2 |
|
2010 |
2012 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.320 |
None |
1.000 |
2 |
|
2012 |
2017 |
Suffering, Physical
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Pain, Migratory
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Epileptic Syndromes
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
High Risk Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Infantile Spasm
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
93
|
39
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |